ConductScience.org, home

Paper2434597

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.

Zalman LS and 3 others. J Exp Med, 1987. Cited by 162 papers, by iCite.

Cite this record

ConductScience Library. Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria. Papers, record 2434597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2434597

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.
PubMed
Journal
J Exp Med
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
4.09
iCite
Revised in PubMed
2019-05-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zalman LSL S
2Wood LML M
3Frank MMM M
4Müller-Eberhard HJH J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood ProteinsMajor topic
CD59 AntigensMajor topic
Carrier ProteinsMajor topic
Erythrocyte MembraneMajor topic
Hemoglobinuria, ParoxysmalMajor topic
Membrane ProteinsMajor topic
CD55 Antigens
Cell Separation
Complement Inactivator Proteins
Hemolysis
Humans
Immune Sera

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-17354NIAID NIH HHSUnited StatesP01AI017354PubMed and NIHNIH RePORTER
HL-07195NHLBI NIH HHSUnited StatesT32HL007195PubMed and NIHNIH RePORTER
HL-16411NHLBI NIH HHSUnited StatesP01HL016411PubMed and NIHNIH RePORTER

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16776186Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.J Immunol1980https://conductscience.org/library/papers/6776186PubMed
22428045Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/2428045PubMed
36211481Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.J Immunol1982https://conductscience.org/library/papers/6211481PubMed
46222136Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.J Exp Med1983https://conductscience.org/library/papers/6222136PubMed
56576376Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6576376PubMed
66225118Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6225118PubMed
76238120Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.J Exp Med1984https://conductscience.org/library/papers/6238120PubMed
83964820Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.J Immunol1985https://conductscience.org/library/papers/3964820PubMed
92581259Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/2581259PubMed
102986594Physicochemical behaviour and structural characteristics of membrane-bound acetylcholinesterase from Torpedo electric organ. Effect of phosphatidylinositol-specific phospholipase C.Biochem J1985https://conductscience.org/library/papers/2986594PubMed
112581636Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system.Blood1985https://conductscience.org/library/papers/2581636PubMed
122409211Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.J Exp Med1985https://conductscience.org/library/papers/2409211PubMed
133860874Enhanced complement-mediated lysis of type III paroxysmal nocturnal hemoglobinuria erythrocytes involves increased C9 binding and polymerization.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/3860874PubMed
142413153Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.J Exp Med1985https://conductscience.org/library/papers/2413153PubMed
152416869Decay-accelerating factor is present on cultured human umbilical vein endothelial cells.J Exp Med1986https://conductscience.org/library/papers/2416869PubMed
162419413Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.J Immunol1986https://conductscience.org/library/papers/2419413PubMed
172419414Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.J Immunol1986https://conductscience.org/library/papers/2419414PubMed
182422313Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.J Exp Med1986https://conductscience.org/library/papers/2422313PubMed
196946459Homologous species restriction in lysis of erythrocytes by terminal complement proteins.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6946459PubMed

Download CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
37371574(Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins II: Intercellular Transfer of Matter (Inheritance?) That Matters.Biomolecules2023https://conductscience.org/library/papers/37371574PubMed
35806423Biological Role of the Intercellular Transfer of Glycosylphosphatidylinositol-Anchored Proteins: Stimulation of Lipid and Glycogen Synthesis.Int J Mol Sci2022https://conductscience.org/library/papers/35806423PubMed
34680568Chip-Based Sensing of the Intercellular Transfer of Cell Surface Proteins: Regulation by the Metabolic State.Biomedicines2021https://conductscience.org/library/papers/34680568PubMed
33802150Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to Cells In Vitro Depend on the (Pre-)Diabetic State in Rats and Humans.Biomedicines2021https://conductscience.org/library/papers/33802150PubMed
31739586Relating GPI-Anchored Ly6 Proteins uPAR and CD59 to Viral Infection.Viruses2019https://conductscience.org/library/papers/31739586PubMed
19707355Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.Biologics2008https://conductscience.org/library/papers/19707355PubMed
19281793Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59.Biochem Biophys Res Commun2009https://conductscience.org/library/papers/19281793PubMed
8389477Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8389477PubMed
8200963Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor.J Clin Invest1994https://conductscience.org/library/papers/8200963PubMed
8153873Membrane proteins that protect against complement lysis.Springer Semin Immunopathol1994https://conductscience.org/library/papers/8153873PubMed
7507156Membrane defence against complement lysis: the structure and biological properties of CD59.Immunol Res1993https://conductscience.org/library/papers/7507156PubMed
3655659Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes.J Exp Med1987https://conductscience.org/library/papers/3655659PubMed
3366469The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.Immunology1988https://conductscience.org/library/papers/3366469PubMed
3309123Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor.J Exp Med1987https://conductscience.org/library/papers/3309123PubMed
3260383Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granules.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3260383PubMed
2738160Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.J Clin Invest1989https://conductscience.org/library/papers/2738160PubMed
2478585Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.J Clin Invest1989https://conductscience.org/library/papers/2478585PubMed
2475570CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.J Exp Med1989https://conductscience.org/library/papers/2475570PubMed
2471198Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2471198PubMed
2448783Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2448783PubMed

See all 30 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACHE43PubTator's text mininghttps://conductscience.org/library/genes/43NCBI Gene
CD551604PubTator's text mininghttps://conductscience.org/library/genes/1604NCBI Gene
TPT17178PubTator's text mininghttps://conductscience.org/library/genes/7178NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2434597

GET https://conductscience.org/api/papers/v1/2434597/cited_by?page=2